Device |
test, cell mediated immune response, liver and small bowel transplant/transplantation |
Definition |
The test is a qualitative prognostic test intended to be used in patients less than 21 years old with liver or small bowel transplantation. The test is an aid in the evaluation of the risk of acute cellular rejection (ACR) and must be used in conjunction with biopsy, standard clinical assessment and other laboratory information. |
Physical State |
flow cytometers, fluorochrome labeled antibodies, sodium heparin blood collection tubes, processing reagents, automated processing devices or pipetting devices. |
Technical Method |
Stimulated Cell Culture |
Target Area |
Peripheral human whole blood specimens |
Review Panel |
Clinical Chemistry |
Product Code | PHK |
Premarket Review |
Office of In Vitro Diagnostics
(OHT7)
Division of Chemistry and Toxicology Devices
(DCTD)
|
Not Classified Reason
|
HDE
|
Submission Type |
HDE - Humanitarian Device Exemption
|
Device Class |
Not Classified
|
Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
GMP Exempt? |
No
|
Summary Malfunction Reporting |
Eligible |
Implanted Device? |
No
|
Life-Sustain/Support Device? |
No
|
Third Party Review |
Not Third Party Eligible |